These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20661575)

  • 1. Targeting cancer-derived extracellular vesicles by combining CD147 inhibition with tissue factor pathway inhibitor for the management of urothelial cancer cells.
    Boddu VK; Zamzow P; Kramer MW; Merseburger AS; Gorantla SP; Klinger M; Cramer L; Sauer T; Gemoll T; von Bubnoff N; Gieseler F; Darabi M
    Cell Commun Signal; 2024 Feb; 22(1):129. PubMed ID: 38360687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cluster of differentiation 147 (CD147) as potential membrane protein biomarker for bladder cancer cells.
    Roslan A; Said DS; Sulaiman N; Mohd Ghani KA; Nurdin A
    J Pharm Biomed Anal; 2023 Nov; 236():115729. PubMed ID: 37778199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bladder cancer update: what was new at the 2010 annual congress of the German Association of Urology in Düsseldorf?].
    Nawroth R; Hartmann A; Olbert PJ; Merseburger AS; Stöhr R; Knüchel R; Retz M; Füssel S
    Urologe A; 2011 Feb; 50(2):221-6. PubMed ID: 21246347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemotherapy for urothelial cancer of the bladder--update 2012].
    Niegisch G; Lorch A; Albers P
    Aktuelle Urol; 2012 Dec; 43(6):412-9. PubMed ID: 23196781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD147/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis.
    Xin X; Zeng X; Gu H; Li M; Tan H; Jin Z; Hua T; Shi R; Wang H
    Sci Rep; 2016 Sep; 6():32804. PubMed ID: 27608940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [EMMPRIN (CD147). A prognostic and potentially therapeutic marker in urothelial cancer].
    Nawroth R; Hartmann A; Wild P; Lehmann J; Stöhr R; Gschwend JE; Retz M
    Pathologe; 2010 Oct; 31 Suppl 2():251-4. PubMed ID: 20661575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [EMMPRIN (CD147). A new key protein during tumor progression in bladder cancer].
    Nawroth R; Stöhr R; Hartmann A; Gschwend JE; Retz M
    Urologe A; 2008 Sep; 47(9):1152-6. PubMed ID: 18688595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emmprin Expression Predicts Response and Survival following Cisplatin Containing Chemotherapy for Bladder Cancer: A Validation Study.
    Hemdan T; Malmström PU; Jahnson S; Segersten U
    J Urol; 2015 Dec; 194(6):1575-81. PubMed ID: 26119672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased RECK and Increased EMMPRIN expression in urothelial carcinoma of the bladder are associated with tumor aggressiveness.
    Wittschieber D; Stenzinger A; Klauschen F; Stephan C; Jung K; Erbersdobler A; Rabien A
    Pathobiology; 2011; 78(3):123-31. PubMed ID: 21613799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emmprin and survivin predict response and survival following cisplatin-containing chemotherapy in patients with advanced bladder cancer.
    Als AB; Dyrskjøt L; von der Maase H; Koed K; Mansilla F; Toldbod HE; Jensen JL; Ulhøi BP; Sengeløv L; Jensen KM; Orntoft TF
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4407-14. PubMed ID: 17671123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-related issues of CD147.
    Weidle UH; Scheuer W; Eggle D; Klostermann S; Stockinger H
    Cancer Genomics Proteomics; 2010; 7(3):157-69. PubMed ID: 20551248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EMMPRIN regulates the canonical Wnt/beta-catenin signaling pathway, a potential role in accelerating lung tumorigenesis.
    Sidhu SS; Nawroth R; Retz M; Lemjabbar-Alaoui H; Dasari V; Basbaum C
    Oncogene; 2010 Jul; 29(29):4145-56. PubMed ID: 20514014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD147 overexpression is a prognostic factor and a potential therapeutic target in bladder cancer.
    Xue YJ; Lu Q; Sun ZX
    Med Oncol; 2011 Dec; 28(4):1363-72. PubMed ID: 20509007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases: regulators of the tumor microenvironment.
    Kessenbrock K; Plaks V; Werb Z
    Cell; 2010 Apr; 141(1):52-67. PubMed ID: 20371345
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.